Trials / Unknown
UnknownNCT00439504
Ph1 Lobeline Interaction Study - 1
Double-Blind, Placebo-Controlled, Cross-Over Assessment of Intravenous Methamphetamine and Sublingual Lobeline Interactions
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 10 (planned)
- Sponsor
- National Institute on Drug Abuse (NIDA) · NIH
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine if there are significant cardiovascular or other interactions between sublingual lobeline and intravenous methamphetamine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lobeline |
Timeline
- First posted
- 2007-02-23
- Last updated
- 2017-01-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00439504. Inclusion in this directory is not an endorsement.